April 25, 2017
NuVasive Inc. announced the launch of the Reline trauma portfolio, which serves as the company’s foundation to address the approximate $100 million U.S. spine trauma fixation market, according to a company press release.
“The launch of Reline trauma is a key milestone in our continued commitment to industry-leading innovation that delivers untapped clinical and economic value for our surgeon partners,” Jason Hannon, president and chief operating officer of NuVasive, said in the release. “Reline trauma will help define the standard of trauma care for spine, with its ability to dramatically reduce time and provide complete versatility intraoperatively. The system will be the foundation of our trauma portfolio as we invest further in this key market.”